Lido Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.09M Buy
241,095
+64,992
+37% +$1.66M 0.02% 413
2025
Q4
$4.5M Buy
176,103
+9,232
+6% +$236K 0.01% 491
2025
Q3
$4.28M Buy
166,871
+6,438
+4% +$163K 0.01% 477
2025
Q2
$4.06M Buy
160,433
+4,047
+3% +$100K 0.02% 421
2025
Q1
$3.91M Sell
156,386
-44,808
-22% -$1.11M 0.02% 397
2024
Q4
$4.95M Buy
201,194
+166,891
+487% +$4.18M 0.02% 326
2024
Q3
$882K Sell
34,303
-2,356
-6% -$59.5K ﹤0.01% 761
2024
Q2
$900K Buy
36,659
+2,436
+7% +$59.5K 0.01% 699
2024
Q1
$849K Buy
34,223
+23,772
+227% +$589K 0.01% 725
2023
Q4
$264K Buy
+10,451
New +$249K ﹤0.01% 1095

Other funds holding IBDX

Lido Advisors's IBDX Position: Q1 2026 in Review

Lido Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 37% in Q1 2026, buying an estimated $1.66M and bringing the position to 241,095 shares worth $6.09M. The position accounts for 0.02% of the portfolio, ranked #413.

Lido Advisors first reported a position in IBDX in Q4 2023 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Lido Advisors held 241,095 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $6.09M as of Q1 2026.
  • Lido Advisors bought 64,992 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $1.66M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.02% of Lido Advisors's portfolio in Q1 2026, its #413 holding.
  • Lido Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.